MK

Mukesh Kumar

Active Director Director DIN 08759643
DIN 08759643 First appointment Jun 2020 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Mukesh Kumar

Data last updated:

Mukesh Kumar is a Director at Genem Biotech Private Limited (since 2020). The company operates in Life Sciences. Genem Biotech Private Limited reported revenue of ₹51.5 Lakh (FY 2025).

DIN 08759643
Primary Designation Director
Industry Life Sciences
First Appointment 11 Jun 2020
Oldest Company Age 6 yrs
Largest company Genem Biotech Private Limited · ₹51.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genem Biotech Private Limited U33127BR2020PTC046306
Director11 Jun 20202020₹51.5 Lakh (FY 2025)Active

Board colleagues of Mukesh Kumar

NameDINCompanyDesignation
Sunita Kumari08759644Genem Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genem Biotech Private Limited
Premium access

Shareholding and investment profile for Mukesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Kumar

Mukesh Kumar currently holds 1 directorship: Genem Biotech Private Limited (Director, since 11 Jun 2020, revenue ₹51.5 Lakh (FY 2025)).

Mukesh Kumar was first appointed on 11 Jun 2020 as Director at Genem Biotech Private Limited.

The current boards of Mukesh Kumar's companies include Sunita Kumari (Genem Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available